RELEReleases

MedTech Outlook Names ARMS Medical’s VNEW Top Pelvic Floor Tech of 2026

MedTech Outlook has named VNEW, a mesh-free dermal allograft from Fort Lauderdale-based ARMS Medical, the top pelvic floor surgery technology for 2026. The selection, determined by an expert panel, highlights the product's unique design approach, which prioritizes anatomical precision over the adaptation of existing surgical materials.

Bio & NewsOctober 1, 2026712 reads0

The development of VNEW followed a shift in perspective for ARMS Medical, moving from material-first engineering to a patient-centric model. By spending thousands of hours observing urogynecologists and colorectal surgeons, the company focused on the specific requirements of female anatomy. This led to a product that arrives at the operating room hydrated and precut in four anatomical shapes, eliminating the need for surgical teams to manually prepare or measure tissue during procedures.

At the core of the technology is dCELL, a proprietary decellularization process that removes donor DNA while retaining the structural integrity of the collagen and vascular channels. To date, more than 200 surgeons have utilized VNEW in over 10,000 cases. Robert Greer, CEO of ARMS Medical, noted that the recognition serves as a milestone rather than a conclusion, as the company continues to refine its offerings based on ongoing feedback from clinicians and patients.

Comments (0)

Leave a comment

No comments yet. Be the first!